DermTech, Inc. (DMTKQ)

DermTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	15.66	15.3	14.52	11.84	5.89	3.36
Revenue Growth (YoY)	9.71%	5.36%	22.64%	101.16%	74.94%	37.76%
Cost of Revenue	14.33	15.02	13.87	10.56	5.98	3.3
Gross Profit	1.33	0.28	0.65	1.27	-0.1	0.06
Selling, General & Admin	79.44	88.78	94.76	62.41	29.9	15.17
Research & Development	14.1	15.24	24.05	16.26	5.29	2.5
Operating Expenses	93.54	104.02	118.81	78.67	35.19	17.67
Operating Income	-92.2	-103.74	-118.17	-77.4	-35.29	-17.61
Other Expense / Income	-2.57	-2.85	-1.48	0.94	1.19	2.53
Pretax Income	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13
Net Income	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13
Shares Outstanding (Basic)	35	33	30	29	17	7
Shares Outstanding (Diluted)	35	33	30	29	17	7
Shares Change	13.58%	8.66%	4.00%	70.12%	142.39%	58.81%
EPS (Basic)	-2.68	-3.09	-3.88	-2.71	-2.15	-2.87
EPS (Diluted)	-2.68	-3.09	-3.88	-2.71	-2.15	-2.87
Free Cash Flow	-72.22	-77.88	-98.57	-64.83	-30.52	-18
Free Cash Flow Per Share	-2.08	-2.39	-3.28	-2.24	-1.80	-2.57
Gross Margin	8.51%	1.80%	4.46%	10.76%	-1.63%	1.78%
Operating Margin	-588.62%	-678.21%	-813.92%	-653.81%	-599.64%	-523.34%
Profit Margin	-572.19%	-659.57%	-803.71%	-661.72%	-619.83%	-598.39%
Free Cash Flow Margin	-461.03%	-509.16%	-678.92%	-547.61%	-518.57%	-535.11%
EBITDA	-84.05	-95.04	-112.22	-76.04	-35.99	-20.04
EBITDA Margin	-536.57%	-621.35%	-772.99%	-642.33%	-611.57%	-595.75%
Depreciation & Amortization	5.58	5.85	4.46	2.3	0.49	0.09
EBIT	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13
EBIT Margin	-572.19%	-659.57%	-803.71%	-661.72%	-619.83%	-598.39%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).